BANCO MACRO SA-ADR (BMA)

US05961W1053 - ADR

80.01  -1.79 (-2.19%)

After market: 80.01 0 (0%)

Fundamental Rating

4

BMA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 404 industry peers in the Banks industry. Both the profitability and financial health of BMA have multiple concerns. BMA is valued quite expensive, but it does show an excellent growth.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past 5 years BMA has always been profitable.
In multiple years BMA reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of BMA (5.16%) is better than 99.75% of its industry peers.
BMA has a better Return On Equity (18.93%) than 96.51% of its industry peers.
Industry RankSector Rank
ROA 5.16%
ROE 18.93%
ROIC N/A
ROA(3y)4.51%
ROA(5y)4.21%
ROE(3y)16.17%
ROE(5y)16.7%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of BMA (12.84%) is worse than 78.05% of its industry peers.
BMA's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for BMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 12.84%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.35%
PM growth 5Y-6.18%
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BMA has about the same amount of shares outstanding.
Compared to 5 years ago, BMA has less shares outstanding
Compared to 1 year ago, BMA has a worse debt to assets ratio.

2.2 Solvency

A Debt/Equity ratio of 0.14 indicates that BMA is not too dependend on debt financing.
BMA has a Debt to Equity ratio of 0.14. This is in the better half of the industry: BMA outperforms 66.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

9

3. Growth

3.1 Past

BMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 415.48%, which is quite impressive.
BMA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 102.57% yearly.
BMA shows a strong growth in Revenue. In the last year, the Revenue has grown by 296.55%.
BMA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 119.85% yearly.
EPS 1Y (TTM)415.48%
EPS 3Y170.06%
EPS 5Y102.57%
EPS Q2Q%-408.36%
Revenue 1Y (TTM)296.55%
Revenue growth 3Y139.02%
Revenue growth 5Y119.85%
Sales Q2Q%-24.94%

3.2 Future

BMA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.94% yearly.
BMA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 65.50% yearly.
EPS Next Y6.26%
EPS Next 2Y2.16%
EPS Next 3Y28.94%
EPS Next 5YN/A
Revenue Next Year311.2%
Revenue Next 2Y70.77%
Revenue Next 3Y65.5%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BMA's earnings are expected to grow with 28.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.16%
EPS Next 3Y28.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BMA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BANCO MACRO SA-ADR

NYSE:BMA (11/21/2024, 7:10:20 PM)

After market: 80.01 0 (0%)

80.01

-1.79 (-2.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.12B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 18.93%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 12.84%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)415.48%
EPS 3Y170.06%
EPS 5Y
EPS Q2Q%
EPS Next Y6.26%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)296.55%
Revenue growth 3Y139.02%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y